Cadila Healthcare gains 3% on USFDA approval to market hypertension drug
USFDA has given more than 180 approvals to the Cadila Healthcare group. The group has so far filed over 310 abbreviated new drug applications since it commenced filings in FY04. On Thursday, the Cadila Healthcare shares gained more than 3 percent…